In agreement with recent studies using a different brain-permeable SIRT2 inhibitor (Bai et al. 2022; Wang et al. 2020; Biella et al. 2016), spatial learning, memory abilities and amyloid pathology were improved by 33i treatment in our study. Here, SIRT2 is linked to amyloidosis.